Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 6, 1996, Pages 1520-1525

  Tateda, Kazuhiro ^a   Takashima, Katsunori ^a   Miyazaki, Hiroyasu ^a   Matsumoto, Tetsuya ^a   Hatori, Tsutomu ^b   Yamaguchi, Keizo ^a  

^a TOHO UNIVERSITY   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; IMIPENEM; PENICILLIN G; VANCOMYCIN;

ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; DOSE RESPONSE; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; LUNG CLEARANCE; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0029890521     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.6.1520     Document Type: Article

References (28)

1. Appelbaum, P. C. 1992. Antimicrobial resistance m Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
2. Austrian, R. 1986 Pneumococcal pneumonia. Diagnosis, epidemiologic, therapeutic and prophylactic considerations. Chest 90:738-743.
3. Azoulay-Dupuis, E., E. Vallee, B. Veber, J. P. Bedos, J. Bauchet, and J. J. Pocidalo. 1992. In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia. Antimicrob. Agents Chemother 36:2698-2703.
4. Barakett, V., D. Lesage, F. Delisle, G. Richard, and J. C. Petit. 1994. Killing kinetics of imipenem against penicillin-resistant Streptococcus pneumoniae. J. Antimicrob. Chemother. 33:1025-1028.
5. Barry, B., M. Muffat-Joly, P. Gehanno, and J. J. Pocidalo. 1993. Effect of increased dosages of amoxicillin in treatment of experimental middle ear otitis due to penicillin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 37:1599-1603.
6. Bingen, E., C. Doit, R. Farinotti, and N. Lambert-Zechovsky. 1993. Killing kinetics of cefuroxime against Streptococcus pneumoniae in an in vitro model simulating serum concentration profiles after intramuscular administration Eur. J. Clin. Microbiol. Infect. Dis. 12:297-299.
7. Caputo, G. M., P. C. Appelbaum, and H. H. Liu. 1993. Infections due to penicillin-resistant pneumococci Clinical, epidemiologic, and microbiologic features Arch. Intern Med 153:1301-1310.
8. Catalan, M. J., J. M. Fernandez, A. Vazquez, E. V. de Seijas, A. Suarez, and J. C. L. B. de Quiros. 1994 Failure of cefotaxime m the treatment of meningitis due to relatively resistant Streptococcus pneumoniae. Clin. Infect Dis. 18:766-769.
9. Doit, C. P., S. P. Bonacorsi, A. J. Fremaux, G. Sissia, R. Cohen, P. L. Geslin, and E. H. Bingen. 1994. In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis Antimicrob. Agents Chemother. 38:2655-2659.
10. Ducharme, M. P., R. L. Slaughter, and D. J. Edwards. 1994. Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight. Ther. Drug Monit. 16:513-518.
11. Feldman, C., J. M. Kallenbach, S. D. Miller, J. R. Thorburn, and H. J. Koornhof. 1985. Community-acquired pneumonia due to penicillin-resistant pneumococci. N. Engl. J Med. 313:615-617.
12. Friedland, I. R., M. Paris, S. Shelton, and G. H. McCracken. 1994. Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae J. Antimicrob. Chemother. 34:231-237
13. Goldstein, F. W., P. Geslin, J. F. Acar, and the French Study Group. Comparative activity of teicoplanin and vancomycin against 400 penicillin-susceptible and resistant Streptococcus pneumoniae. Eur. J. Clin. Microbiol. Infect. Dis. 13:33-34.
14. Gray, B., and H. C. Dillon. 1986. Clinical and epidemiologic studies of pneumococcal infection in children Pediatr Infect. Dis. 5:201-207
15. Heikkila, A. M., and R. U. Erkkola. 1993. The need for adjustment of dosage regimen of penicillin V during pregnancy Obstet. Gynecol 81:919-921
16. Knudsen, J. D., N. Frimodt-Moller, and F. Espersen. 1995. Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin. Antimicrob Agents Chemother. 39:1253-1258.
17. Loo, V. G., J. Lavellee, D. McAlear, and H. G. Robson. 1994 The in-vitro susceptibilities of 326 Streptococcus pneumoniae isolates to nine antimicrobial agents including penicillin and newer quinolones. J. Antimicrob. Chemother. 33:641-645.
18. MacFarlane, J. T., R. G. Finch, M. J. Ward, and A. D. MacRae. 1982 Hospital study of adult community-acquired pneumonia. Lancet ii:255-258
19. McCracken, G. H., Jr., and Y. Sakata. 1985. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin Antimicrob. Agents Chemother. 27:141-145.
20. Moine, P., E. Vallee, E. Azoulay-Dupuis, P. Bourget, J. P. Bedos, J. Bauchet, and J. J. Pocidalo. 1994. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model. Antimicrob. Agents Chemother. 38:1953-1958.
21. Mouton, J. W., and J. N. van den Anker. 1995. Meropenem clinical pharmacokinetics. Clin Pharmacokinet 28:275-286.
22. National Committee for Clinical Laboratory Standards. 1992. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 2nd ed. Approved standard NCCLS Document M7-A2, vol 10, no 8. National Committee for Clinical Laboratory Standards, Villanova, Pa.
23. Pallares, R., F. Gudiol, J. Linares, J. Ariza, G. Rufi, L. Murgui, J. Dorca, and P. F. Viladrich. 1987. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N. Engl. J Med. 317:18-22
24. Paris, M. M., S. M. Hickey, M. I. Uscher, S. Sharon, K. D. Olsen, and G. H. McCracken, Jr. 1994. Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis Antimicrob. Agents Chemother. 38:1320-1324.
25. Rondanelli, R., R. V. Dionigi, M. Calvi, M. Dell'Antonio, G. Corsico, and A. Mapelli. 1987. Cefotaxime therapy of lower respiratory tract infections in intensive-care patients. Int. J. Clin. Pharmacol. Res. 7:73-76.
26. Spika, J. S., R. R. Facklam, B. D. Plikaytis, M. J. Oxtoby, and the Pneumococcal Surveillance Working Group. 1991. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. J. Infect Dis. 163: 1273-1278.
27. Takashima, K., K. Tateda, T. Matsumoto, T. Ito, Y. Iizawa, and K. Yamaguchi. 1995. Experimental respiratory tract infection caused by penicillin-resistant Streptococcus pneumoniae in CBA/J mice. Ther. Res. 16:433-436 (In Japanese with English abstract.)
28. Woodhead, M. A., J. T. MacFarlane, J. S. McCracken, D. H. Rose, and R. G. Finch. 1987. Prospective study of the aetiology and outcome of pneumonia in the community Lancet i:671-674.